You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MT-101

Showing 1 - 25 of 1,623
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

Recruiting
  • Lymphoma, T-Cell, Peripheral
  • +4 more
  • MT-101
  • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
  • Duarte, California
  • +8 more
Jan 27, 2023

Parkinson's Disease Trial in Secaucus (MT101-5)

Completed
  • Parkinson's Disease
  • Secaucus, New Jersey
    Frontage Clinical Services, 1nc.
Apr 25, 2023

Healthy Adult Males Trial in Shinjuku-ku (MT-3921, Placebo)

Completed
  • Healthy Adult Males
  • MT-3921
  • Placebo
  • Shinjuku-ku, Tokyo, Japan
    Clinical Research Hospital Tokyo
Jan 16, 2023

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
Has Results
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

DLBCL Trial in Japan (MT-2111)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Nagoya-shi, Aichi, Japan
  • +3 more
Jan 12, 2023

Transcranial Direct Current Stimulation (tDCS), Transcranial Random Noise Stimulation (tRNS) Trial (tRNS, tDCS, sham

Not yet recruiting
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Random Noise Stimulation (tRNS)
  • tRNS
  • +3 more
  • (no location specified)
Feb 8, 2023

Multiple Myeloma Trial in Worldwide (bb2121)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • San Francisco, California
  • +47 more
Jul 18, 2022

SARS-CoV-2 Infection Trial in Osaka-shi, Suita-shi, Shinjuku-ku (MT-2766 High dose, Placebo, MT-2766 Low dose)

Active, not recruiting
  • SARS-CoV-2 Infection
  • MT-2766 High dose
  • +2 more
  • Osaka-shi, Osaka, Japan
  • +2 more
Mar 25, 2022

Multi-Center Clinical Database of Infants for Investigation of

Enrolling by invitation
  • Infant Development
    • Birmingham, Alabama
    • +7 more
    Aug 16, 2022

    Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in United States (Indoximod, Ipilimumab, Nivolumab)

    Completed
    • Metastatic Melanoma
    • +2 more
    • Augusta, Georgia
    • +5 more
    Jun 3, 2020

    Spinal Muscular Atrophy 1 Trial in Columbus (AVXS-101)

    Completed
    Has Results
    • Spinal Muscular Atrophy 1
    • AVXS-101
    • Columbus, Ohio
      Nationwide Children's Hospital
    Aug 30, 2022

    Stroke, Cerebrovascular Disorders, CNS Diseases Trial in Taoyuan City (Virtual Reality-based Mirror Therapy (VR+MT), Mixed

    Not yet recruiting
    • Stroke
    • +2 more
    • Virtual Reality-based Mirror Therapy (VR+MT)
    • +2 more
    • Taoyuan City, Taiwan
      Taoyuan Chang Gung Memorial Hospital
    Jun 6, 2023

    Anemia; Hemodialysis Dependent Chronic Kidney Disease Trial in Japan (MT-6548, Darbepoetin alfa, MT-6548-matching )

    Completed
    Has Results
    • Anemia; Hemodialysis Dependent Chronic Kidney Disease
    • Aichi, Japan
    • +27 more
    Aug 2, 2021

    Uremic Pruritus Trial in United States (Nalfurafine HCl(MT-9938) 2.5µg, Nalfurafine HCl(MT-9938) 5µg, Nalfurafine HCl(MT-9938)

    Terminated
    Has Results
    • Uremic Pruritus
    • Nalfurafine hydrochloride(MT-9938) 2.5μg
    • +3 more
    • Los Angeles, California
    • +3 more
    Jan 12, 2022

    Multi-drug Resistant Organism Trial in Atlanta (Microbiome Therapeutic, Placebo)

    Not yet recruiting
    • Multi-drug Resistant Organism
    • Microbiome Therapeutic
    • Placebo
    • Atlanta, Georgia
    • +4 more
    Apr 18, 2023

    Adults With Overweight and Obesity Trial (Mindfulness training + real tDCS, Mindfulness training + sham tDCS)

    Not yet recruiting
    • Adults With Overweight and Obesity
    • Mindfulness training + real tDCS
    • Mindfulness training + sham tDCS
    • (no location specified)
    May 9, 2023

    Mood Disorder (Depressive Episodes) Trial (The mini apps named "SOUL GYM" on the Wechat)

    Not yet recruiting
    • Mood Disorder (Depressive Episodes)
    • The mini apps named "SOUL GYM" on the Wechat
    • (no location specified)
    May 19, 2023

    Emotional Stress Trial in Belgium (Mindfulness Training)

    Recruiting
    • Emotional Stress
    • Mindfulness Training
    • Antwerpen, Belgium
    • +10 more
    Mar 8, 2022

    Depression, Anxiety, Insomnia Trial in Haikou, Xinxiang, Nanjing (The Online intervention platform)

    Recruiting
    • Depression
    • +2 more
    • The Online intervention platform
    • Haikou, Hainan, China
    • +2 more
    Jul 16, 2023

    Treatment Resistant Depression, Visual Perceptual Weakness Trial in Hangzhou (Repetitive Transcranial Magnetic Stimulation)

    Not yet recruiting
    • Treatment Resistant Depression
    • Visual Perceptual Weakness
    • Repetitive Transcranial Magnetic Stimulation
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Zhejiang University
    Sep 12, 2023

    Stroke, Pain Trial in Taipei (mirror therapy, tDCS, sham mirror therapy)

    Recruiting
    • Stroke
    • Pain
    • mirror therapy
    • +3 more
    • Taipei, Taiwan
      National Taiwan University
    Nov 28, 2022

    Stroke Trial in Izmit (VAN assessment, VES assessment, LARIO assessment)

    Active, not recruiting
    • Stroke
    • VAN assessment
    • +2 more
    • İzmit, Kocaeli, Turkey
      Kocaeli University
    Sep 6, 2023

    B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)

    Recruiting
    • B Acute Lymphoblastic Leukemia
    • B Lymphoblastic Lymphoma
    • Blinatumomab
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2021

    Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

    Not yet recruiting
    • Chronic Hepatitis b
    • Auckland, New Zealand
      New Zealand Clinical Research Auckland
    Jul 26, 2023